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Abstract
The antihyperglycaemic and antioxidant activities of a Ghanaian medicinal plant namely Adenia lobata Engl
(Passifloraceae), used to treat diabetes mellitus in traditional medicine, was investigated. The dried stem powder of A. lobata was
successively extracted by Soxhlet with petroleum ether and 70% ethanol to obtain the crude petroleum ether (PEAL: yield
=1.1w/w %) and ethanol (EEAL: yield = 5.4 w/w %) extracts. The extracts were assessed for their antihyperglycaemic and
antioxidant activities. The antihyperglycaemic activity of PEAL and EEAL were determined in streptozotocin-induced diabetic
rats (70 mg/kg body weight). Five groups of diabetic rats were given 150, 300 and 600 mg/kg body weight of PEAL and EEAL
orally once daily for 20 days. Glibenclamide (5 mg/kg body weight) was used as positive control while distilled water (5 ml)
acted as the normal diabetic control. The blood glucose levels were monitored initially for 6 hours and subsequently over 24 days.
Both extracts exhibited statistically significant (p< 0.001) antihyperglycaemic activity throughout the study period, with EEAL
showing the greatest activity. The antioxidant properties of the petroleum ether and ethanol extracts of A. lobata (PEAL and
EEAL) were evaluated using five assays; total phenolic content, total antioxidant capacity, reducing power, DPPH scavenging
effect and lipid peroxidation activity. In all these assays, the antioxidant properties increased with increasing concentration of the
extracts.
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Introduction
Diabetes mellitus is a chronic metabolic disorder in which the pancreas produces little or no insulin to meet the body's
needs or the body cannot effectively use the insulin that is produced (Herfindal and Gourley,1996). This results in increased
concentrations of glucose in the blood, which in turn damage many of the body's systems, in particular the blood vessels and
nerves. The development of this disease is associated with an increased presence of free radicals in the body. The production of
these radicals leads to oxidative stress on the body and results in cellular damage (Kuhn, 2003; Johansen et al., 2005). This
damage may lead to many diseases such as diabetes, hypertension and stroke (Chen et al., 2002). Antioxidants are protective
agents that inactivate the reactive oxygen species (ROS) which caused cell damage (Tiwari and Rao, 2002). Hypoglycaemic
medicinal plants with antioxidant agents may be beneficial in diabetes because of their ability to mop up ROS (Mendel, 1997). In
Ghana, the use of medicinal plants in various ethno-botanical literatures has been reported (Irvine, 1961; Mshana et al., 2000;
Abbiw, 1990), while several reputable traditional health practitioners continue to make claims for medicinal plants in the
management of diabetes. It is in this direction that the stem of A. lobata, a woody climber, which grows in the West African
rainforests and used in treatment of diabetes (Irvine, 1961) was investigated.
Materials and Methods
Plant material
The stem of A. lobata was collected from Bobiri forest in Ghana on December 2009 by Mr Osafo Asare, a herbalist.
Authentication was done at the Department of Botany, University of Ghana, Legon by a botanist, Mr. Amponsah. A voucher
specimen with number (KNUST/HM1/2010/S-005 for A. lobata) is deposited at the Faculty of Pharmacy and Pharmaceutical
Science herbarium.
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Method of extraction
The stem of A. lobata was air-dried for ten days at room temperature and milled into a coarse powder. The powder
(650.0 g) was Soxhlet extracted sequentially using petroleum ether (PEAL) and 70% ethanol (EEAL). The extracts were
concentrated to viscous liquids under reduced pressure using a rotary evaporator. The viscous liquids were further evaporated to
solvent-free, semi-solid masses over water bath (yield; PEAL: 1.1 w/w %, EEAL: 5.4 w/w %) and kept in a desiccator until needed
for use. The preliminary phytochemical evaluation of part of powdered stem of A. lobata using standard methods as described by
Harbone, 1998. Revealed the presence of reduced sugars, steroids and phenolic compounds. Large scale Soxhlet extraction by
70% v/v ethanol was done for 3 kg of the powder.
Animals
Adult male sprague-dowley rats (280-295 g) were housed at a standard condition of room temperature and supplied with
standard pellet food with tap water ad libitum in animal house at the Department of Pharmacology, University of Ghana, Legon.
The rats were obtained from the Centre for Scientific Research into Plant Medicine at Mampong-Akwapim, Ghana. All rats were
treated in accordance with the National Institute of Health Guidelines for the care and use of laboratory animals (NIH,
Department of Health and Human Services publication Number 85, revised 1985).
The research protocol was approved by the College of Health Sciences Ethics Committee.
Preliminary phytochemical screening of ethanol extract of A. lobata
The preliminary phytochemical screening of ethanol extract of the stem of A. lobata was carried out using standard
procedures described by Harbone (1998).
Assessment of Antioxidant effects
Total Phenolic Content
The Folin-Ciocalteu’s reagent with tannic acid as standard as described by Slinkard and Singleton (1977) was used to
determine the total phenolic content of the extracts. Aliquots (1 ml) of tannic acid and each extract (0.50, 0.75, 1.00 and 1.50
mg/ml) were added to 1 ml distilled water and 1ml Folin-Ciocalteu’s reagent in a test tube. The samples were allowed to stand
after mixing for 5 minutes at 25oC in an incubator. A 2% sodium bicarbonate solution (1 ml) was added and the mixture incubated
for 2 hours at 25oC. The test tubes were centrifued at 3000 rpm for 10 minutes and the absorbances of supernatants determined at
760 nm. Distilled water (1 ml) was added to 1 ml Folin-Ciocalteu’s reagent and used as blank after going through the same
process. Three replicates were prepared for each concentration of the extracts and tannic acid. The total phenolic acid was
expressed as Tannic acid equivalent (TAE) per weight of the extract (mg/g).
Total antioxidant capacity
The total antioxidant capacity was determined using the method described by Prieto et al. (1999). Different
concentrations of extracts (0.50, 0.75, 1.00, 1.50 mg/ml) and ascorbic acid as standard were added 3 ml of solution (0.6 M H2SO4,
28 mM Na2HPO4 and 4 mM ammonium molybdate). The samples were incubated for 90 minutes at 25oC after shaking, and were
centrifuged at 3000 rpm for 10 minutes. The absorbance of the supernatant was then determined at 695 nm. Distilled water (1 ml)
was used as blank processed in the same way. The total antioxidant capacity was expressed as ascorbic acid equivalent (AAE) per
dry weight of extract (mg/g).
Reducing Power
This assay was based on the method described by Oyaizu (1986). using N-propyl gallate as standard. One millilitre of
extracts (0.50, 0.75, 1.00, 1.50 mg/ml) or N-propyl gallate was added to 1ml of water, mixed with 2.5 ml of phosphate buffer (0.2
M, pH 6.6) and 2.5 ml of 1% potassium ferricyanide. The mixture was incubated for 20 minutes at 50oC, trichloroacetic acid (2.5
ml) was added and samples centrifuged at 3000 rpm for 10 minutes. The absorbance of the mixture was measured at 700 nm after
2.5 ml of the supernatant has been mixed with 2.5 ml distilled water and 0.5 ml of 0.1% FeCl3. The blank (1 ml distilled water,
2.5 ml phosphate buffer and 2.5 potassium ferricyanide) in a test tube was processed in the same pattern. The reducing power was
expressed as N-propyl gallate equivalent (NPGE) per dry weight of extract (mg/g).
Free radical scavenging activity
The method described by Blois (1958). Was used to determine the free radical scavenging activity of the extracts. One
millilitre of methanolic DPPH solution (20 mg/l) was added firstly to 3 ml of extract solution, then to 3ml of pure methanol
(blank). The mixtures were incubated for 30 minutes and the various absorbances were measured at 517 nm. The reference drug
was N-propyl gallate (1-30 mg/ml). The percentage inhibition of DPPH by the samples was calculated according to the formula:
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where A is absorbance of control;
As the absorbance of sample.
The IC50 values (the concentration in mg/ml at 50% inhibition) were determined from the curves between percentage
inhibition and logarithmic sample concentration.
Linoleic acid autoxidation
This assay is based on the method according to Mitsuda et al. (1996). The extracts (0.50-1.50 mg/ml) dissolved in
absolute alcohol were compared directly with N-propyl gallate dissolved in absolute alcohol, as the reference antioxidant. Equal
volumes (2 ml) of the extracts and 2.5% linoleic acid in absolute ethanol, 4 ml of 0.05 M phosphate buffer (pH-7) and 1.9 ml of
distilled water were put into test tube with screw cap and incubated in the dark at 40oC for 7 days. Two millilitres of the sample
solutions were added to 1 ml of 20% aqueous trichloroactetic acid solution and 1 ml of 0.6% aqueous thiobarbituric acid solution.
The samples were placed in boiling water bath for 10 minutes, allowed to cool to room temperature, and then centrifuged at 3000
rpm for 10 minutes. The absorbance of the supernatants was measured at 490 nm. The % inhibition of linoleic acid autoxidation
was calculated as follows:
% Inhibition
where
Co (Full reaction mixture) is the degree of lipid peroxidation in the absence of antioxidant
Ci is the underlying lipid peroxidation before the initiation of lipid peroxidation
D is any absorbance produced by the extract
Di is the absorbance produced by the extract alone.
Assessment of antihyperglycaemic effect of STZ-induced diabetic rats
The bioassay model employed was according to the description of Nagarajan et al. (2005) with slight modification.
Induction of diabetes in rats
Streptozotocin (0.588 g) was dissolved in freshly prepared 0.1M citrate buffer of pH-4.5. The normal blood glucose
level of the rats was taken and was found to be in the range of (3.8-4.9 mmol/l). Rats were injected intraperitoneally with a single
dose of 70 mg/kg body weight streptozotocin after 12 hours fast. After injection, rats were given free access to feed and water.
After a rest period of 48 hours, diabetes was confirmed by determing the fasting blood glucose levels. Rats with blood glucose
level above 10.0 mmol/l were selected for the experiment.
Effect of extract on diabetic rats
The diabetic rats were randomly divided into five groups of five animals each: Groups A, B, C, D and E. The petroleum
ether, PEAL and 70% v/v ethanol, EEAL were suspended in 2% tragacanth solution. Groups A, B and C were given oral doses of
150, 300 and 600 mg/kg body weight of PEAL respectively. Group D was given an oral dose of 5 mg/kg body weight of
glibenclamide, a standard anti hyperglycaemic agent, as positive control, and Group E was given 5 ml/kg body weight distilled
water as normal control. The experiment was repeated using EEAL with new sets of animals.
Blood glucose level measurement
Blood glucose levels were initially monitored hourly over six hours starting at 0 hour after drug administration to see
the immediate effects of both extracts on the diabetic rats. The glucose level was subsequently monitored on a three-day interval
basis over the next 24 days for A. lobata extracts. Blood samples were collected from tail vein using Accu-Chek® glucometer
(Roche Diagnostics GmbH, Mannheim Germany). Throughout the study period, rats received standard diet and water every
morning.
Statistical analysis
All the data provided in this study represents means ± S.E.M. The results were analysed by one-way ANOVA followed
by Bonferroni’s multiple comparison test to establish significance (p 0.001) between the treated and the control groups.
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Results
Antihyperglycaemic effect of extracts
The blood glucose levels of the untreated diabetic rats (diabetic control) after 6 hours increased by 28.4 % (Table 1).
The blood glucose levels of diabetic rats treated with PEAL at doses of 150, 300 and 600 mg/kg body weight decreased
by 19.9, 32.2 and 47.1 % respectively after the 6th hour.
Table 1: Effect of PEAL in streptozotocin-induced diabetic rats after 6 hours
All values are expressed as mean ± S.E.M. (N = 5); Number in the parentheses denotes percentage reduction (blood glucose
level) after 6 hours; PEAL = petroleum ether extract of the stem of A. lobata; GB = Glibenclamide; PEAL treated groups were
compared with control group (p 0.001)
Table 2: Effect of PEAL in streptozotocin-induced diabetic rats after 24 days
TREATMENT AND DOSE
PEAL
(150 mg/kg)
PEAL
(300 mg/kg)
PEAL
(600 mg/kg)
GB
(5 mg/kg)
Control
(5 ml/kg)TIME
(days) Blood Glucose Level (mmol/l)
0.0 25.6±2.0 24.5±1.3 27.4±2.4 23.2±3.0 24.4±0.9
3.0 19.5±1.9 16.1±0.5 16.2±1.1 14.7±0.2 31.8±0.4
6.0 17.7±1.7 12.9±0.6 12.0±0.2 12.5±0.4 32.0±0.4
9.0 15.7±1.9 11.8±0.4 11.4±0.2 10.4±0.3 32.3±0.3
12.0 14.6±1.9 10.4±0.4 10.1±0.3 9.7±0.3 32.2±0.3
150.0 14.0±1.7 9.2±0.4 8.8±0.3 7.6±0.2 32.4±0.4
18.0 13.4±1.8 8.4±0.4 8.0±0.3 7.5±0.2 32.1±0.3
21.0 12.6±1.8 7.6±0.3 7.0±0.2 6.1±0.2 32.3±0.3
24.0 12.0±1.8 6.9±0.3 6.2±0.2 4.7±0.4 32.7±0.2
(53.1) (71.8) (77.4) (79.7) (-34.0)
All values are expressed as mean ± S.E.M. (N=5); Number in the parentheses denotes percentage reduction (blood glucose level)
after 24 days; PEAL = petroleum ether extract of the stem bark of A. lobata; GB = Glibenclamide; PEAL treated groups were
compared with control group (p 0.001).
Those treated with EEAL at doses of 150, 300 and 600 mg/kg had their blood glucose levels lowered by 36.7, 41.1 and
51.7 % respectively within the same period (Table 2). Glibenclamide, the standard antidiabetic drug (5 mg/kg) lowered the blood
glucose levels by 54.7 %. The extracts at the selected doses and glibenclamide showed significant antihyperglycaemic activities
(p< 0.001) as compared to the diabetic control group 6 hours after treatment. On the 24th day, untreated diabetic (diabetic control)
rats had 34.0 % increase in blood sugar level. PEAL administered at 150, 300, and 600 mg/kg body weight decreased the blood
glucose levels by 53.1, 71.8 and 77.4 respectively (Table 2).
BLOOD GLUCOSE LEVEL (mmol/l)
TREATMENT AND
DOSE
TIME (hrs)
0 1 2 3 4 5 6
PEAL
(150 mg/kg)
25.6±2.0 24.3±2.2 23.7±2.2 23.1±2.2 21.9±2.0 21.0±1.9 20.5±1.8
(19.9)
PEAL
(300 mg/kg)
24.5±1.1 21.0±0.7 19.9±0.9 18.9±1.0 18.3±0.9 17.4±0.9 16.6±0.7
(32.2)
PEAL
(600 mg/kg)
27.4±2.4 19.9±1.0 19.0±0.9 17.2±1.7 16.0±1.5 15.4±1.4 14.5±1.2
(47.1)
GB
(5 mg/kg)
23.2±3.0 18.7±2.4 15.9±2.1 13.3±2.2 12.7±2.1 12.1±2.0 10.5±1.5
(54.7)
Control
(5 ml/kg)
24.4±0.9 25.6±1.4 25.3±1.7 26.7±0.8 27.3±1.1 28.0±0.9 28.4±1.0
(-28.4)
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Table 3: Effect of EEAL in streptozotocin-induced diabetic rats after 6 hours
All values are expressed as mean ± S.E.M. (N = 5); Number in the parentheses denotes percentage reduction (blood glucose level)
after 6 hours; EEAL = 70% Ethanol extract of the stem bark of A. lobata; GB = Glibenclamide; EEAL treated groups were
compared with control group (p 0.001).
On the other hand, EEAL at 150, 300, and 600 mg/kg body weight decreased the blood glucose levels by 71.4, 78.2 and
82.8 % respectively (Table 4). Glibenclamide (5 mg/kg body weight) lowered the blood glucose by 79.7 %. Throughout the study,
EEAL at all the selected doses exhibited the greatest antihyperglycaemic activity compared to those of PEAL. The
antihyperglycaemic activity of EEAL at 600 mg/kg body weight was comparable to that of the standard drug, glibenclamide
(Table 4). Both extracts (PEAL and EEAL) and the standard drug demonstrated statistically significant antihyperglycaemic
activity (p< 0.001) when compared to the diabetic control group.
Table 4: Effect of EEAL in streptozotocin-induced diabetic rats after 24 days
TREATMENT AND DOSE
EEAL
(150 mg/kg)
EEAL
(300 mg/kg)
EEAL
(600 mg/kg)
GB
(5 mg/kg)
Control
(5 ml/kg)
TIME
(days)
Blood Glucose Level (mmol/l)
0.0 25.5±1.5 27.5±1.2 30.2±0.7 23.2±3.0 24.4±0.9
3.0 15.1±1.2 13.0±1.5 12.2±1.1 14.7±0.2 31.8±0.4
6.0 13.5±1.1 11.6±1.5 10.7±0.9 12.5±0.4 31.9±0.4
9.0 12.0±1.0 10.5±1.2 9.6±0.7 10.4±0.3 32.3±0.3
12.0 11.0±0.9 9.1±1.1 8.5±0.3 9.7±0.3 32.2±0.3
15.0 9.8±0.6 7.8±0.8 7.2±0.1 7.6±0.2 32.4±0.4
18.0 9.3±0.5 7.6±0.7 6.3±0.1 7.5±0.2 32.1±0.3
21.0 7.9±0.4 7.1±0.7 5.9±0.1 6.1±0.2 32.3±0.3
24.0 7.3±0.2 6.0±0.4 5.2±0.1 4.7±0.4 32.7±0.2
(71.4) (78.2) (82.8) (79.7) (-34.0)
All values are expressed as mean ± S.E.M. (N=5); Number in the parentheses denotes percentage reduction (blood glucose level)
after 24 days; EEAL = 70% ethanol extract of the stem bark of A. lobata; GB = Glibenclamide; EEAL treated groups were
compared with control group (p 0.001).
BLOOD GLUCOSE LEVEL (mmol/l)
TREATMENT AND
DOSE
TIME (hours)
0 1 2 3 4 5 6
EEAL
(150 mg/kg)
25.5±1.5 21.4±1.0 19.6±1.4 18.2±1.0 16.9±1.0 16.4±1.0 15.9±1.1
(36.7)
EEAL
(300 mg/kg)
27.5±1.2 22.9±1.1 20.6±0.8 19.4±1.2 18.9±1.3 17.6±0.7 16.2±0.5
(41.1)
EEAL
(600 mg/kg)
30.2±0.7 21.5±1.9 19.5±1.4 17.8±0.9 16.8±0.7 16.2±0.7 14.6±0.6
(51.7)
GB
(5 mg/kg)
23.2±3.0 18.7±2.4 15.9±2.1 13.3±2.2 12.7±2.1 12.1±2.0 10.5±1.5
(54.7)
Control
(5 ml/kg)
24.4±0.9 25.6±1.4 25.3±1.7 26.7±0.8 27.3±1.1 28.0±0.9 28.4±1.0
(-16.4)
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Antioxidants activity of extracts
Total phenolic content (TPC) of A. lobata extracts
The absorbance of A. lobata extracts increased with increasing concentration of the extracts. The total phenolic content
expressed as tannic acid equivalent (TAE) in mg/g weight of extract for EEAL was 0.623 ± 0.040 and 0.513 ± 0.041 for PEAL
(Table 5).
Table 5: Antioxidants activities of extracts
Sample
Test Parameter EEAL PEAL NPG
Total phenolic content TAE(mg/g) 0.623 ± 0.0400 0.513 ± 0.0410
Antioxidant capacity AAE(mg/g) 0.687 ± 0.0640 0.556 ± 0.0520
Reducing power NPG(mg/g) 0.645 ± 0.0990 0.348 ± 0.0390
FRSA IC50 0.5210 ± 0.0057 2.106 ± 0.0082 0.2917 ± 0.0054
Lipid autoxidation IC50 0.5985 ± 0.0081 8.593 ± 0.0900 0.4217 ± 0.0061
EEAL = 70% Ethanol extract of Adenia lobata; PEAL = Petroleum ether extract of Adenia lobata; NPG = N-propyl gallate;
TAE = Tannic acid equivalent; AAE = Ascorbic acid equivalent; FRSA = Free radical scavenging activity; IC50 = Effective
concentration at 50% inhibition
Total antioxidant capacity (TAC) of A. lobata extract
PEAL and EEAL showed relatively good antioxidant capacities. EEAL exhibited a higher total antioxidant capacity
than PEAL. The total antioxidant capacity expressed as ascorbic acid equivalent (AAE) mg/g dry weight of extract were 0.687 ±
0.064 for EEAL and 0.556 ± 0.052 for PEAL (Table 5). EEAL is therefore a better antioxidant than PEAL.
Reducing power of A. lobata extracts
The absorbance of the extracts increased with increasing concentration of the extracts. EEAL exhibited a higher
reducing power than PEAL. The reducing power expressed as N-propyl gallate equivalent (NPGE) mg/g dry weight of extract
were 0.645 ± 0.099 for EEAL and 0.348 ± 0.039 for PEAL. EEAL is therefore a better antioxidant than PEAL (Table 5).
DPPH scavenging effect of A. lobata extract
The free radical scavenging activity of A. lobata extracts expressed as percentage inhibition of DPPH shows
concentration-dependent activity for all the extracts. The IC50 values of the N-propyl gallate, EEAL and PEAL were 0.2917 ±
0.0054, 0.5210 ± 0.0057, 2.106 ± 0.0082 mg/ml respectively (Table 5). EEAL was found to be the most active free radical
scavenger of the two extracts.
Lipid peroxidation of A. lobata extract
The IC50 values of lipid autoxidation inhibition were 0.5985 ± 0.0081 for EEAL and 8.593 ± 0.0090 mg/ml for PEAL.
The reference drug, N-propyl gallate, had an IC50 of 0.4217 ± 0.0061 mg/ml (Table 5). All the extracts and N-propyl gallate
showed concentrations-dependent inhibition of lipid peroxidation activities.
Discussion
Antihyperglycaemic of extracts
Diabetes is a global health problem and its complications are associated with an increased presence of free radicals that
lead to elevated stress in the body (Mendel, 1997; Johansen et al., 2005). Elimination of the generated free radicals and lipid
peroxidation products can prevent further damage to the body tissue in diabetes. Free radicals and oxidative stress have been
implicated in the aetiology of diabetes and its complications. The present study demonstrated the anithyperglycaemic activity of
the petroleum ether extract (PEAL), 70% ethanol extract (EEAL) of A. lobata in streptozotocin-induced diabetic rats in acute and
sub-chronic treatment study periods. All the extracts progressively lowered the blood glucose levels in the diabetic rats throughout
the study period. Blood glucose levels measured in the first 6 hours were to see the short term effect of the extracts following
administration of the extracts. After one to six hours following drug treatment using 600 mg/kg body weight of EEAL, it was
observed that the blood glucose lowering effect was more than the effects observed when an equivalent dose of PEAL was used.
Evaluation of blood glucose level after 20 days was to see the sub-chronic or long term effect of the test drugs. EEAL at 600
mg/kg body weight was more active than PEAL in this long term treatment. The differences in activities of the extracts may be
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due to the type of constituents that are present in the extracts. EEAL having been obtained using a relatively polar solvent
principally contained polar constituents, whereas PEAL principally contained non-polar constituents. Poly-phenols, sterols and
flavonoids found in ethanol extract of Butea monosperma were found to be responsible for antihyperglycaemic effect in
streptozotocin-induced diabetic rats (Bavarva and Narasimhacharya, 2008). From the preliminary phytochemical screening,
reducing sugars and phenolic compounds were found in EEAL and steroids were found in PEAL, and these may be partly
responsible for the antihyperglycaemic activity of the extract.
Antioxidants of extracts
Five different assays namely, total phenolic contents, total antioxidant capacity, reducing power, DPPH scavenging
effect, and lipid peroxidation, were used to evaluate the antioxidant capacities of both A. lobata and extracts. Though A. lobata
was among four medicinal plants assessed qualitatively based on the DPPH preliminary studies for their antioxidant potential
(Mamyrbekova-Bekro et al., 2008), extensive quantitative work has not yet been reported. The tests on both petroleum ether and
ethanolic extracts of A. lobata (PEAL, EEAL) showed relatively good antioxidant capacities. The total phenol was assayed based
on the reduction of phosphomolbdate salts to form a blue complex that was detected quantitatively at 760 nm. The phenolic
content of PEAL and EEAL was expressed as tannic acid equivalent and was found to increase with increasing concentration of
the extracts. The total antioxidant capacity of the extracts determined as ascorbic acid equivalent also increased with increasing
extract concentration. The reducing capacity of a compound also served as a significant indicator of its potential antioxidant
activity (Hsu et al., 2006). The reductive ability of the extracts was measured in relation to their capacity to reduce Fe3+ to Fe2+.
PEAL, EEAL and the reference antioxidant, N-propyl gallate showed concentration-dependent reduction of Fe3+ to Fe2+. From
the results (Table 5), N-propyl gallate and EEAL were better antioxidant agents than PEAL. PEAL and EEAL exhibited their
capabilities to scavenge DPPH. The percentage DPPH scavenging effect increased with increasing concentration of the extracts.
The order of potency as defined by IC50 in mg/ml showed that the ethanol extract (EEAL of IC50 = 0.5210 ± 0.0057) had better
scavenging ability than the petroleum ether extract (PEAL of IC50 = 2.106 ± 0.0082). In all cases, the N-propyl gallate of IC50 =
0.2917± 0.0054 was found to have the best scavenging ability (Table 5). Phenolic compounds are known to possess DPPH radical
scavenging property (Velioglu et al., 1998) and may be responsible for the effects observed in the extracts of A. lobata. The
results show that EEAL and PEAL are capable of inhibiting the formation of peroxides and hydroperoxides by removing free
radicals. This inhibition process could prevent chronic vascular complications such as neuropathy, retinopathy, nephropathy and
heart disease (Alexandra et al., 2003). Generally, the polar extracts (EEAL) had relatively good antioxidant potentials than their
respective petroleum ether extracts (PEAL) as shown, and this justified the traditional formulation as an aqueous decoction
(Irvine, 1961; Abbiw, 1990).
5.0 Conclusion
It is reported in this study for the first time that the extracts of A. lobata exhibited promising antihyperglycaemic
activity in streptozotocin-induced diabetic rats. This study has also established the antioxidant potentials of the stem of A. lobata.
The extracts of these medicinal plants were found to be capable of removing free radicals that caused damage to body tissues. The
antioxidant activity of the extracts may represent a protective mechanism against reactive oxygen species (ROS) associated with
chronic hyperglycaemia and diabetic complications.
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